Skip to content

Pathway construction and effectiveness evaluation of AI-enhanced influenza vaccination advocacy by primary healthcare providers for chronic obstructive pulmonary disease patients

Pathway construction and effectiveness evaluation of AI-enhanced influenza vaccination advocacy by primary healthcare providers for chronic obstructive pulmonary disease patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129244
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Comparison:Usual care
Intervention:intelligent intervention
Observation group:None

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Permanent residents under institution management who have the opportunity to receive influenza vaccine advocacy and vaccination services during the study observation period; 2.Patients with a confirmed diagnosis of COPD based on past medical records, health records, or a physician’s diagnosis; 3.Age >= 40 years; 4.Able to obtain influenza vaccination outcomes through health records, follow-up records, or the vaccination information system; 5.The participant has provided informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Expected to move away during the study period, making follow-up impossible; 2.Existing, clear contraindications to influenza vaccination; 3.Already vaccinated with the influenza vaccine for the current influenza season prior to the start of the study; 4.Cognitive impairment, severe mental illness, or other reasons preventing participation in follow-up, and no representative available to assist; 5.Already participating in other intervention studies that may influence influenza vaccination behavior.

Design outcomes

Primary

MeasureTime frame
Influenza vaccination rate among patients with COPD;

Secondary

MeasureTime frame
Satisfaction;Percentage of patients who received advocacy for influenza vaccine;Influenza vaccination advocacy rate among primary care providers;Influenza vaccination interval;

Countries

China

Contacts

Public ContactChi Chunhua

Peking University First Hospital

chichunhua2012@qq.com+86 10 8357 5505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026